Synopsys (NASDAQ:SNPS - Get Free Report) issued its quarterly earnings data on Wednesday. The semiconductor company reported $3.35 EPS for the quarter, topping analysts' consensus estimates of $3.17 by $0.18, FiscalAI reports. Synopsys had a net margin of 13.76% and a return on equity of 6.83%. The firm had revenue of $2.28 billion for the quarter, compared to analyst estimates of $2.25 billion. Synopsys updated its FY 2026 guidance to 14.720-14.800 EPS and its Q3 2026 guidance to 3.630-3.690 EPS.
Synopsys Stock Performance
Shares of NASDAQ:SNPS traded down $8.64 during trading on Wednesday, reaching $525.92. 2,382,788 shares of the company's stock traded hands, compared to its average volume of 1,990,614. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.36 and a quick ratio of 1.26. Synopsys has a 12 month low of $376.18 and a 12 month high of $651.73. The company has a 50 day moving average of $455.56 and a 200-day moving average of $452.78. The stock has a market capitalization of $100.75 billion, a P/E ratio of 81.66, a price-to-earnings-growth ratio of 4.30 and a beta of 1.25.
Analyst Upgrades and Downgrades
A number of equities analysts have commented on the stock. Rosenblatt Securities boosted their price objective on shares of Synopsys from $530.00 to $575.00 and gave the stock a "buy" rating in a report on Tuesday. Wells Fargo & Company boosted their price objective on shares of Synopsys from $450.00 to $505.00 and gave the stock an "equal weight" rating in a report on Thursday, May 14th. HSBC lowered shares of Synopsys from a "buy" rating to a "hold" rating and set a $455.00 price objective on the stock. in a report on Friday, February 20th. Needham & Company LLC restated a "buy" rating on shares of Synopsys in a research note on Thursday, February 26th. Finally, The Goldman Sachs Group set a $600.00 target price on shares of Synopsys and gave the company a "buy" rating in a research note on Wednesday, February 25th. Eight equities research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Hold" and an average price target of $544.88.
View Our Latest Stock Report on SNPS
Institutional Investors Weigh In On Synopsys
A number of institutional investors have recently modified their holdings of SNPS. State Street Corp grew its position in shares of Synopsys by 20.6% during the 3rd quarter. State Street Corp now owns 8,760,358 shares of the semiconductor company's stock valued at $4,322,273,000 after buying an additional 1,493,912 shares during the last quarter. Farallon Capital Management LLC bought a new stake in shares of Synopsys during the 4th quarter valued at about $469,344,000. Primecap Management Co. CA grew its position in Synopsys by 743.6% in the 4th quarter. Primecap Management Co. CA now owns 734,800 shares of the semiconductor company's stock worth $345,150,000 after purchasing an additional 647,700 shares during the last quarter. Amundi grew its position in Synopsys by 53.9% in the 4th quarter. Amundi now owns 1,700,906 shares of the semiconductor company's stock worth $798,950,000 after purchasing an additional 596,018 shares during the last quarter. Finally, Marshall Wace LLP grew its position in Synopsys by 184.2% in the 4th quarter. Marshall Wace LLP now owns 755,948 shares of the semiconductor company's stock worth $355,084,000 after purchasing an additional 489,952 shares during the last quarter. Institutional investors own 85.47% of the company's stock.
More Synopsys News
Here are the key news stories impacting Synopsys this week:
- Positive Sentiment: Synopsys raised FY 2026 EPS guidance to 14.72-14.80, topping the consensus estimate of 13.61, while revenue guidance of $9.6 billion-$9.7 billion was in line to slightly ahead of expectations.
- Positive Sentiment: The company also lifted third-quarter 2026 EPS guidance to 3.63-3.69 versus the 3.42 consensus estimate, with revenue guidance of $2.4 billion-$2.5 billion also matching or modestly exceeding forecasts.
- Positive Sentiment: Rosenblatt Securities raised its price target on Synopsys to $575 from $530 and reiterated a buy rating, signaling additional upside confidence ahead of the earnings report. Benzinga
- Neutral Sentiment: Investors are also watching the company’s earnings release and its Ansys merger integration, both of which could influence sentiment and future guidance. Blockonomi
- Neutral Sentiment: Some pre-earnings commentary suggested Synopsys could report softer quarterly results and highlighted valuation concerns, but these reports were outweighed by the company’s stronger-than-expected outlook. Benzinga
- Negative Sentiment: Bearish articles described Synopsys as a “growth trap,” raising concerns about the stock’s longer-term growth profile and valuation in the EDA industry. 247wallst
About Synopsys
(
Get Free Report)
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Synopsys, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.
While Synopsys currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.